Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9782483
SERIAL NO

13698718

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention refers to the use of a sigma ligand, preferably a sigma ligand of formula (I), to prevent or treat emesis induced by a chemotherapeutic agent or radioactivity, especially emesis induced by taxanes, vinca alkaloids or platin chemotherapeutic drugs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LABORATORIOS DEL DR ESTEVE S AAV MARE DE DEU DE MONTSERRAT 221 BARCELONA E-08041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Codony-Soler, Xavier Mataró-Barcelona, ES 5 43
Vela, Hernández José Miguel Barcelona, ES 11 51
Zamanillo-Castanedo, Daniel Barcelona, ES 24 99

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00